| pubmed-article:8362913 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8362913 | lifeskim:mentions | umls-concept:C0015576 | lld:lifeskim |
| pubmed-article:8362913 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:8362913 | lifeskim:mentions | umls-concept:C0028326 | lld:lifeskim |
| pubmed-article:8362913 | lifeskim:mentions | umls-concept:C1708726 | lld:lifeskim |
| pubmed-article:8362913 | lifeskim:mentions | umls-concept:C0027832 | lld:lifeskim |
| pubmed-article:8362913 | lifeskim:mentions | umls-concept:C0023745 | lld:lifeskim |
| pubmed-article:8362913 | lifeskim:mentions | umls-concept:C0332125 | lld:lifeskim |
| pubmed-article:8362913 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8362913 | pubmed:dateCreated | 1993-9-30 | lld:pubmed |
| pubmed-article:8362913 | pubmed:abstractText | A linkage analysis has been performed on 6 two-generation families with classical Noonan syndrome to determine whether the syndrome is linked to neurofibromatosis type 1 on chromosome 17q or to neurofibromatosis type 2 on chromosome 22q. A significantly negative location score was obtained between 10 cM centromeric to and 15 cM telomeric from the neurofibromatosis type 1 locus. A significantly negative lod score was obtained with a marker mapping within the region where neurofibromatosis type 2 is thought to be located. These data indicate that Noonan syndrome is not tightly linked to either neurofibromatosis type 1 or type 2. | lld:pubmed |
| pubmed-article:8362913 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8362913 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8362913 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8362913 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8362913 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:8362913 | pubmed:issn | 0148-7299 | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:LevilliersJJ | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:FlintoffW FWF | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:GilgenkrantzS... | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:KachanerJJ | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:MunnichAA | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:LyonnetSS | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:LacombeDD | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:MarçonFF | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:Le MerrerMM | lld:pubmed |
| pubmed-article:8362913 | pubmed:author | pubmed-author:BahuauMM | lld:pubmed |
| pubmed-article:8362913 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8362913 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:8362913 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:8362913 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8362913 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8362913 | pubmed:pagination | 700-5 | lld:pubmed |
| pubmed-article:8362913 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:meshHeading | pubmed-meshheading:8362913-... | lld:pubmed |
| pubmed-article:8362913 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8362913 | pubmed:articleTitle | No evidence for linkage to the type 1 or type 2 neurofibromatosis loci in Noonan syndrome families. | lld:pubmed |
| pubmed-article:8362913 | pubmed:affiliation | Unité de Recherches sur les Handicaps Génétiques de l'Enfant INSERM, Paris, France. | lld:pubmed |
| pubmed-article:8362913 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8362913 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8362913 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8362913 | lld:pubmed |
